Clinical Trial Update: EMERALD TRIAL Open Label Extension Study [Phase 4]

View source ↗

Summary

Open-label extension study update for the EMERALD trial (Phase 4) with conditions including amyotrophic lateral sclerosis and cannabis-related terms; current st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Gold Coast Hospital and Health Service | Conditions: Amyotrophic Lateral Sclerosis, Cannabis | Phase 4 | Status: UNKNOWN